These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7331685)

  • 1. Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
    Yamada K; Suzuki H; Kato Y
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1080-5. PubMed ID: 7331685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
    Sueyama H; Oguro M; Takagi T
    Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.
    Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Maruyama Y; Tomiyama J
    Cancer Res; 1990 Dec; 50(23):7587-92. PubMed ID: 2253209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Kimura K; Yamada K; Uzuka Y; Maekawa T; Takaku F; Shimoyama M; Ogawa M; Amaki I; Osamura S; Ito M; Sakai Y; Oguro M; Hattori K; Hoshino A; Hirota Y; Ohta K; Nakamura T; Masaoka T; Kimura I; Ichimaru M
    Recent Results Cancer Res; 1981; 76():232-40. PubMed ID: 7232852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pharmacokinetic studies of high dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Yoshida T; Nakamura S; Ohtake S; Ito K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1820-4. PubMed ID: 3592717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) by 30-minute infusion with acute nonlymphocytic leukemia--the possibility of administration for outpatients].
    Hirosawa S
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1991-3. PubMed ID: 3164182
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
    Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A phase II study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC].
    Kimura K
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2475-81. PubMed ID: 3619459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of cytokinetic and biochemical features of acute leukemia cells.
    Omine M; Tsuchiya J; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1004-21. PubMed ID: 7331683
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
    Takenaka T; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
    [No Abstract]   [Full Text] [Related]  

  • 11. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.
    Nagura E; Kimura K; Yamada K; Ohta K; Maekawa T; Takaku F; Uchino H; Masaoka T; Amaki I; Kawashima K
    Cancer Chemother Pharmacol; 1994; 34(1):23-9. PubMed ID: 8174198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
    Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypoplastic leukemia--clinical effects of low-dose 4N-behenoyl-beta-D-arabinofuranosylcytosine (BH-AC) therapy].
    Nakada H; Takahashi I; Yorimitu S; Hara M; Ohmoto E; Inagaki T; Aoyama S; Nishimura M; Hayashi N; Sekito N
    Rinsho Ketsueki; 1987 Apr; 28(4):534-40. PubMed ID: 3476764
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
    Takubo T; Tani Y; Kubota Y; Oguma S; Ueda T; Nakamura H; Shibata H; Masaoka T
    Nihon Gan Chiryo Gakkai Shi; 1984 Feb; 19(1):1-7. PubMed ID: 6597236
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Yamada K; Kawashima K; Kato Y; Morishima Y; Tanimoto M; Ohno R
    Recent Results Cancer Res; 1980; 70():219-29. PubMed ID: 6766563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated cycles of G-CSF-combined postremission chemotherapy for acute myeloid leukemia in a first complete remission: a pilot study.
    Ogata K; An E; Kamikubo K; Yokose N; Tamura H; Yamada T; Gomi S; Dan K; Nomura T
    Stem Cells; 1998; 16(4):280-7. PubMed ID: 9708450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment with a small dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in a case of chronic myelomonocytic leukemia in blastic crisis].
    Tsukada J; Misago M; Sato T; Kikuchi M; Nakata K; Nagata K; Mori N; Otani H; Oda S; Chiba S
    Rinsho Ketsueki; 1989 Jan; 30(1):61-6. PubMed ID: 2716200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)].
    Hirano M; Morishita Y; Ino T; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Saito M
    Rinsho Ketsueki; 1981 Mar; 22(3):299-305. PubMed ID: 6944508
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.
    Takashima Y
    J Clin Pharmacol; 1988 Apr; 28(4):356-62. PubMed ID: 3164731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
    Hirano M; Morita A; Sako F; Uetani T; Koie K
    Rinsho Ketsueki; 1972 Dec; 13(6):951-7. PubMed ID: 4675066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.